Study discovers a feedback mechanism that could help maintain insulin production in overweight sufferers.

‘Stimulating the ILC2 cells, which trigger the release of insulin in overweight individuals using retinoic acid and could be used to inhibit the failure of insulin production.’

The research conducted by scientists at the Department of Endocrinology, Diabetes and Metabolism at University Hospital Basel and the University of Basel's Department of Biomedicine gives an insight into an inflammatory network that could contribute to the maintenance of insulin production in diabetics. The complex interactions between endocrine cells and immune cells are clearly significant for the maintenance of insulin release. 




It is already known that obesity and diabetes lead to an excessive, pathological activation of the immune system in which the messenger substance IL1-beta plays a central role. This results in the death of insulin-producing cells. However, if IL1-beta is blocked, diabetes and its complications - in particular cardiovascular diseases - can be inhibited. Diabetic inflammatory reactions are already finding use in clinical applications.
Source-Eurekalert